價(jià)格 | ¥228 | ¥578 | ¥868 |
包裝 | 1mg | 5mg | 10mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2025-02-28 |
中文名稱(chēng):羥基法舒地爾鹽酸鹽 | 英文名稱(chēng):Hydroxyfasudil Hydrochloride |
CAS:155558-32-0 | 品牌: TargetMol |
產(chǎn)地: 美國(guó) | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
純度規(guī)格: 99.82% | 產(chǎn)品類(lèi)別: 抑制劑 |
貨號(hào): T4276 |
名稱(chēng) | Hydroxyfasudil Hydrochloride |
描述 | Hydroxyfasudil Hydrochloride (HA 1100 hydrochloride) is a ROCK1/2 inhibitor (IC50s: 0.73/0.72 μM). |
動(dòng)物實(shí)驗(yàn) | Hydroxyfasudil is formulated in saline.Micturition behavior is studied after administration of either Hydroxyfasudil (10 mg/kg, i.p.) or a corresponding volume of saline. Each rat is placed in a metabolic cage containing a urine collection funnel that is placed over an electronic balance. The balance is connected to a personal computer via a multiport controller and used to measure the cumulative weight of the collected urine. Every 150 s during a continuous 24-h period, the computer samples and records the data for the micturition frequency and volumes. The micturition reflex parameters that are collected include: urine volume per micturition, maximal micturition volume, micturition frequency, and total urine output in the Hydroxyfasudil- or vehicle-treated animals. Each monitoring session started at 18.00 hours. Prior to being placed in the metabolic cage at the start of each experimental period, the animals received either a single injection of Hydroxyfasudil (10 mg/kg) dissolved in saline or an injection of saline without the inhibitor. |
體外活性 | Hydroxyfasudil 對(duì) PKA 的抑制作用較弱(IC50: 37 μM),是 ROCKs 的抑制作用的50倍。此外,Hydroxyfasudil 能增加 eNOS mRNA 的水平(EC50: 0.8 ± 0.3 μM),并且以濃度依賴(lài)的方式(0-100 μM)提高 eNOS 活性,刺激 NO 在 HAEC 中的產(chǎn)生。Hydroxyfasudil(10 μM)能將 eNOS mRNA 的半衰期從13小時(shí)增加到16小時(shí),但對(duì) eNOS 啟動(dòng)子活性(0.1-100 μM)無(wú)影響。 |
體內(nèi)活性 | Hydroxyfasudil(10 mg/kg,i.p.)在SD大鼠中顯著增加了最大和平均排尿量。Hydroxyfasudil還顯著降低了膀胱逼尿肌的最大壓力。在自發(fā)性高血壓大鼠(SHRs)中,Hydroxyfasudil(3 mg/kg,i.p.)抑制了由去甲腎上腺素引起的超收縮。此外,Hydroxyfasudil(3/10 mg/kg,i.p.)顯著改善了大鼠陰莖cGMP含量的減少。 |
存儲(chǔ)條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 62 mg/mL (180.3 mM) |
關(guān)鍵字 | HA-1100 | Hydroxyfasudil Hydrochloride | ROCK | Hydroxyfasudil | Rho-associated kinase | HA 1100 | inhibit | HA1100 | HA1100 Hydrochloride | Rho-kinase | Rho-associated protein kinase | HA-1100 Hydrochloride | ROK | Inhibitor | HA 1100 Hydrochloride |
相關(guān)產(chǎn)品 | Y-27632 dihydrochloride | CID-5056270 | ROCK-IN-5 | SB-747651A Dihydrochloride | Fasudil | Tofacitinib | CAY10746 | Y-27632 | RKI-1447 | SAR407899 hydrochloride | Thiazovivin | GSK180736A |
相關(guān)庫(kù) | 抑制劑庫(kù) | 經(jīng)典已知活性庫(kù) | 抗癌化合物庫(kù) | 已知活性化合物庫(kù) | 激酶抑制劑庫(kù) | 神經(jīng)再生化合物庫(kù) | NO PAINS 化合物庫(kù) | 干細(xì)胞分化化合物庫(kù) | TGF-β/Smad靶點(diǎn)化合物庫(kù) | 細(xì)胞重編程化合物庫(kù) |
成立日期 | 2013-04-18 (12年) | 注冊(cè)資本 | 566.265100萬(wàn)人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營(yíng)行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱(chēng) | 價(jià)格 | 公司名稱(chēng) | 報(bào)價(jià)日期 | |
---|---|---|---|---|
¥36000 |
VIP6年
|
西安萊納生物科技有限公司
|
2025-03-20 | |
¥41000 |
VIP12年
|
湖北威德利化學(xué)科技有限公司
|
2025-04-07 | |
詢(xún)價(jià) |
VIP4年
|
江西瑞威爾生物科技有限公司
|
2025-04-02 | |
¥863.90 |
VIP2年
|
上海阿拉丁生化科技股份有限公司
|
2025-02-27 | |
詢(xún)價(jià) |
上海孚一生物科技有限公司
|
2024-03-20 |